Local Infusion, a health care and pharmaceutical startup founded in 2022, has recently received a significant boost with a $10.00M Series A investment from Meridian Street Capital and Blisce on 29 November 2023. The company aims to revolutionize infusion therapy with a focus on improving patient outcomes, saving time for physicians, and making the process more affordable. Its human-centered design and people-first culture emphasize the importance of community, comfort, and connection in the patient and provider experience. Headquartered in the United States, Local Infusion is dedicated to providing a supportive environment for both patients and healthcare professionals at its care centers, aligning with its slogan, "We are setting a new standard for infusion therapy—because patients deserve better." This investment is expected to fuel the company's efforts to reshape the infusion therapy landscape.
No recent news or press coverage available for Local Infusion.